| |
||
|
Catalogue Number |
Product | Order number / Unit |
| |
||
| 9740 | Pentreotide trifluoroacetate |
9740.0001: 1 mg per vial 9740.0010: 10 mg per vial Please inquire for customized filling and bulk quantities.
|
|
Precursor for radiolabelled Pentreotide
Ligand for somatostatin receptors |
||
| Molar Mass: 1394.57 | ||
| C63H87N13O19S2 | ||
| [138661-02-6] (net peptide) | ||
| Colourless to off-white freeze-dried solid packaged in screw cap vials. | ||
| Purity: ≥ 95 % | ||
|
Certificates:
CoA; MS (identity); HPLC (purity) |
||
|
Chemical Name: Sequence: DTPA-D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr(ol), cyclic disulfide DTPA = residue of N-diethylentriamine-N,N,N′,N′′,N′′-pentaacetic acid Supplied as trifluoroacetate salt |
||
|
Synonymes: DTPA-octreotide; DTPA-SMS; SDZ 215-811; Pentetreotide; CA index name: L-Cysteinamide, N-[2-[[2-bis(carboxymethyl)amino]-ethyl](carboxymethyl)amino]ethyl]-N-(carboxymethyl)glycyl-D-phenylalanyl-L-cysteinyl- L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (3→8)-disulfide |
||
|
Literature: Myssiorek D. et al. 111Indium pentetreotide imaging in the evalution of head and neck tumors. Laryngoscope 2005, 115, 1707-1716. |
||
| Rambaldi P.F. et al. The present and future role of 111In pentetreotide in the PET era. Q. J. Nucl. Med.Mol. Imaging. 2005, 49, 225-235. | ||
| date of product catalogue issue: 10 May 2017 | ||